Health gains of smoking cessation: accounting for age and time since smoking cessation
|
|
- Lorraine Watson
- 5 years ago
- Views:
Transcription
1 Health gains of smoking cessation: accounting for age and time since smoking cessation Rudolf Hoogenveen, Pieter van Baal 2006 may 22
2 Contents Background Methodology - Introduction of RIVM Chronic Disease Model - Application of CDM on smoking Data used Analyses and results Conclusions and discussion
3 Background
4 Background - Quantifying the potential effects of tobacco control on burden of disease is useful to support policy makers in setting priorities - However, a problem emerges when trying to estimate possible health gains of smoking cessation: relapse rates, disease risks and thus health gains not only depend on age, but also on time since smoking cessation - Solution: introducing time since cessation next to age in simulation model
5 Methodology Introduction of RIVM Chronic Disease Model (CDM) as starting simulation model for quantifying the effects Application of CDM on smoking
6 RIVM Chronic Disease Model (CDM) CDM is a multi-state Markov-type simulation model to describe the changes of morbidity and mortality from severa chronic diseases resulting from changes of several risk factor in the Dutch population Methodology: - Life course of cohorts are modeled - Model states are defined by risk factor class and by disease state - Change of state prevalence rates are modeled through transitions between states (state-transition, Markov-type) - Disease incidence rates depend on risk factor levels - Mortality rates depend on disease status - All transition rates are specified by gender and age
7 State-transition structure of CDM Transitions between risk factor classes class 1 class 2 class n class transition rates mortality rates mortality Transitions between disease states without disease with disease mortality from other causes of death mortality from disease mortality
8 Application of CDM on smoking That means: - selection of risk factor smoking and all smoking-related diseases - standard CDM version: smoking cessation and disease incidence rates dependent on age - new CDM version: rates dependent on time since smoking cessation
9 Model structure: In case of age-dependent rates: start stop never current former relapse rates depend on age In case of time-dependent rates: continuously stops start stop never current former <1 year former >1 year <2 year former >20 year relapse rates depend on time since smoking cessation
10 Data used
11 Data on smoking behaviour from retrospective survey - initial distribution over never/current/former smoking classes - age-dependent start, stop and relapse rates - relapse rates dependent on time since smoking cessation Disease data from registries in general practice and cancer registries - disease-related excess mortality rates (DisMod) Relative risks from literature - relative risks for disease incidence dependent on age dependent on time since smoking cessation Disability weights from Dutch Burden of Disease Study - disabiliy weights specified by disease to quality-adjust life years
12 Analyses and results
13 Two scenarios on 50 years old current smokers: - (1) current practice - (2) all current smokers quit at start of simulation period Two models: relapse rates and disease incidence rates that depend on - (1) age - (2) time since smoking cessation Results: effects of smoking cessation on: - (1) life years gained - (2) smoking prevalence numbers - (3) disease incidence numbers
14 Life years gained for any quitter dependency model age time total 1,2 2,0 quality-adjusted smoking-related diseases only 1,4 2,5 all diseases (# 71) 1,2 2,0
15 Former smoking prevalence numbers and rates delta former smokers number age time time delta former smokers proportion 0,4 0,35 0,3 0,25 0,2 0,15 0,1 0, time age time
16 Current and cumulative incidence numbers of acute myocardial infarction (AMI) delta AMI incidence number age time -100 time delta cumulative AMI incidence number age time time
17 Conclusions and discussion
18 Not taking into account smoking cessation time results in biased effec measures of interventions Results from simulation models can be sensitive to assumptions regarding the model structure, i.e. transition rates for former smoker that depend on age or on time since cessation Sensitivity results are not uniform, e.g. they depend on the outcome variable and time horizon chosen More complex models require more detailed data, e.g. relative risks used for second model were specified by age and by time since smoking cessation
19 Colleagues involved with this CDM application RIVM PZO RIVM VTV RIVM IMA StiVoRo P van Baal, T Feenstra, R Hoogenveen N Hoeijmans, H Boshuizen, M Willemsen,
Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students
HEALTH EDUCATION RESEARCH Vol.23 no.2 2008 Pages 310 318 Advance Access publication 4 August 2007 Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation
More informationThe potential impact of smoking interventions on HLY in France. W. Nusselder, D. Wapperom, C. Looman, H. Boshuizen for JA EHLEIS
The potential impact of smoking interventions on HLY in France W. Nusselder, D. Wapperom, C. Looman, H. Boshuizen for JA EHLEIS REVES, Edinburgh 28-30 May 2014 Background and aim Tobacco is leading cause
More informationProject Report. Economic model of adult smoking related costs and consequences for England. October 2010 Revised: April 2011
Project Report Economic model of adult smoking related costs and consequences for England October 2010 Revised: April 2011 Christine Godfrey, Shehzad Ali, Steve Parrott, Kate Pickett Department of Health
More informationQuantitative health impact assessment in Copenhagen
Quantitative health impact assessment in Copenhagen - an application of the DYNAMO-HIA model Astrid Ledgaard Holm Henrik Brønnum-Hansen University of Copenhagen Department of Public Health Section of Social
More informationPredicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance
Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance NASEM ENDS Workshop February 2017 Annette M. Bachand, Ph.D. Goal of Statistical Models:
More informationAnnette M. Bachand, 1, Sandra I. Sulsky, 1 and Geoffrey M. Curtin 2
Risk Analysis, Vol. 38, No. 1, 2018 DOI: 10.1111/risa.12819 Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements
More informationThe cost-effectiveness of raising the legal smoking age in California Ahmad S
The cost-effectiveness of raising the legal smoking age in California Ahmad S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each
More informationA complex evaluation of a complex system: Evaluating the smoking cessation system of a Public Health Unit to guide policy change
A complex evaluation of a complex system: Evaluating the smoking cessation system of a Public Health Unit to guide policy change Nadia Minian; Robert Schwartz; John Garcia; Roshan Guna. Background Reducing
More informationEffects of smoking and smoking cessation on productivity in China
Effects of smoking and smoking cessation on productivity in China Team *Hong Wang; MD, PhD **Heng-Fu Zou; PhD I. Introduction *: Yale University; **: World Bank 1. Aim of Project We will study smoking
More informationCost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people:
Cost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people: Economic modelling report M. Raikou, A. McGuire LSE Health, London
More informationComprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics
Study Info Intervention Characteristics Population Characteristics Author, Year: Carter, 2000 Study design: Cost-effectiveness analysis Perspective: Commonwealth and Healthcare sector Location: Australia
More informationUsing the Stages of Change Model to Choose an Optimal Health Marketing Target
UW Biostatistics Working Paper Series 3-16-2010 Using the Stages of Change Model to Choose an Optimal Health Marketing Target Paula Diehr University of Washington, pdiehr@u.washington.edu Peggy A. Hannon
More informationVarenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?
Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks? Sonal Singh M.D., M.P.H, Johns Hopkins University Presented by: Sonal Singh, MD MPH September 19, 2012 1 CONFLICTS
More informationPsychosis & Schizophrenia: The Updated NICE Quality Standard. Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015
Psychosis & Schizophrenia: The Updated NICE Quality Standard Dr Tony Gill Mental Health Practitioner University of Leeds 7 th June 2015 NICE.what is it? The National Institute for Health & Care Excellence
More informationCost-effectiveness of brief intervention and referral for smoking cessation
Cost-effectiveness of brief intervention and referral for smoking cessation Revised Draft 20 th January 2006. Steve Parrott Christine Godfrey Paul Kind Centre for Health Economics on behalf of PHRC 1 Contents
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationReducing Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies
Reducing Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies Summary Evidence Table Evidence Location Costs Benefits American Cancer Society (ACS) 2011 United States 27 states without current
More informationPotential impacts of tobacco tax on health, health inequalities, and health system costs?
1 Potential impacts of tobacco tax on health, health inequalities, and health system costs? Epidemiological and economic modelling in NZ BODE 3 Team (tobacco): Tony Blakely, Linda Cobiac, Amber Pearson,
More informationCost-effectiveness of smoking cessation in Australia with varenicline, a novel pharmacotherapy
Cost-effectiveness of smoking cessation in Australia with varenicline, a novel pharmacotherapy Alissa Brown 1, Kate Webb 1, Hansoo Kim 1, Danny Liew 2 1 Pfizer Australia Pty Ltd 2 St Vincent s Hospital,
More informationProceedings of the 2014 Winter Simulation Conference A. Tolk, S. Y. Diallo, I. O. Ryzhov, L. Yilmaz, S. Buckley, and J. A. Miller, eds.
Proceedings of the 2014 Winter Simulation Conference A. Tolk, S. Y. Diallo, I. O. Ryzhov, L. Yilmaz, S. Buckley, and J. A. Miller, eds. A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE POPULATION LEVEL HEALTH
More informationThe cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden Bolin K, Lindgren B, Willers S Record Status This is a critical abstract of an economic evaluation
More informationPresent value cost-savings to Medicaid over 25 years
cost-savings from switching would be realized 2 relies on assumptions about the fraction of aggregate medical expenditures avoided and the rate at which they are realized over a 25-year period. In particular,
More informationSmoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment
Smoking Cessation at Bladder Cancer Diagnosis: Many Patients Might Benefit from this Teachable Moment Josemanuel Saucedo, BS Jeffrey Bassett, MD, MPH Lorna Kwan, MPH Sarah E. Connor, MPH, CHES William
More informationSimulation-Based Estimates of Effectiveness and Cost- Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease
Simulation-Based Estimates of Effectiveness and Cost- Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease Kokuvi Atsou 1,2, Christos Chouaid 1,2,3, Gilles Hejblum
More informationTobacco use during adolescence may predict smoking during adulthood: simulation-based research
Original article Arch Argent Pediatr 2015;113(2):106-113 / 106 Tobacco use during adolescence may predict smoking during adulthood: simulation-based research Raúl A. Borracci, M.D. a and Andrés H. Mulassi,
More informationThe Netherlands SimSmoke: The Effect of Tobacco Control Policies. On Smoking Prevalence and Tobacco Attributable Deaths in the Netherlands
The Netherlands SimSmoke: The Effect of Tobacco Control Policies On Smoking Prevalence and Tobacco Attributable Deaths in the Netherlands Submitted by David Levy Pacific Institute for Research and Evaluation
More informationDYNAMO-HIA modelling obesity outcomes. Wilma Nusselder Erasmus MC, The Netherlands
DYNAMO-HIA modelling obesity outcomes Wilma Nusselder Erasmus MC, The Netherlands Spotlight meeting The future of research on obesogenic environments, Brussels, November 19th 2015 DYNAMO-HIA DYNAMO-HIA
More informationThe Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need
The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need Ken Warner University of Michigan School of Public Health U.S. E-cigarette Summit, Washington, DC, May 8, 2017 Conflicts
More informationAssociate Professor Gerry Devlin
Associate Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton 9:00-9:15 Secondary Prevention of IHD The Challenge of Secondary Prevention Associate
More informationModelling health outcomes of prevention measures for NRW: potential health gains due to reduced obesity and overweight
Internat. HIA Conference 2-4 Oct, Geneva Modelling health outcomes of prevention measures for NRW: potential health gains due to reduced obesity and overweight Odile Mekel Jutta Grohmann Claudia Terschüren
More informationEconomic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women
Y O R K Health Economics C O N S O R T I U M NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women Supplementary Report
More informationThe Sesim-LEV model. Lisa Brouwers Pontus Johansson Karin Mossler Nils Janlöv Anders Ekholm. Ministry of Health and Social Affairs
The Sesim-LEV model Lisa Brouwers Pontus Johansson Karin Mossler Nils Janlöv Anders Ekholm Ministry of Health and Social Affairs Outline Project aims Model Data Health in SESIM-LEV Results Impact Most
More informationthe cost-effectiveness of smoking cessation support delivered
Eur J Health Econ (2013) 14:789 797 DOI 10.1007/s10198-012-0424-5 ORIGINAL PAPER The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop Carla Guerriero John
More informationModelHealth TM : Tobacco
HealthPartners Institute for Education and Research ModelHealth TM : Tobacco Technical documentation May 2015 Contents Executive summary... 3 Introduction... 3 Community Guide recommendations... 6 State
More informationthe high CVD risk smoker
Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society
More informationCORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW
CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet
More informationNon communicable Diseases in Egypt and North Africa
Non communicable Diseases in Egypt and North Africa Diaa Marzouk Prof. Community Medicine Faculty of Medicine, Ain Shams University Egypt 11 th March 2012 Level of Income North African countries according
More informationPhysicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey
Fact Sheet Physicians for a Smoke-Free Canada A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey The Canadian Tobacco Use Monitoring Survey is conducted annually
More informationGroupe d Analyse Économique An Analysis Group Company
Groupe d Analyse Économique To: From: Canadian Council for Tobacco Control Groupe d Analyse Économique Date: April 9, 2002 Re: Impact of an anti-tobacco campaign on direct health care costs in Canada 1.
More informationMenthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function
Center for Regulatory Effectiveness (CRE) assessment of the following research report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function By: Mark J. Pletcher, MD, MPH; Benjamin
More informationCost-effectiveness of evolocumab (Repatha ) for hypercholesterolemia
Cost-effectiveness of evolocumab (Repatha ) for hypercholesterolemia The NCPE has issued a recommendation regarding the cost-effectiveness of evolocumab (Repatha ). Following NCPE assessment of the applicant
More informationA New Standard of Care: Smoking Cessation Re-engagement Presentation by: Dr. Colleen Webster & Vince Martin, M.S.W.
Kingston Family Health Team A New Standard of Care: Smoking Cessation Re-engagement - 2015 Presentation by: Dr. Colleen Webster & Vince Martin, M.S.W. Participating Family Health Teams Kingston Family
More informationModeling of E-cigarette Use. David Levy, PhD Georgetown University
Modeling of E-cigarette Use David Levy, PhD Georgetown University No Conflicts of Interest Funding has been received for this work from NIDA (NIH) under grant R01DA036497, NCI CISNET U01CA199284, and the
More information1. Comparative effectiveness of liraglutide
Cost-effectiveness of liraglutide (Victoza ) for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise. The NCPE has issued a recommendation regarding
More informationMeasure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use
Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who
More informationTobacco Surveillance and Evaluation: An Update
Tobacco Surveillance and Evaluation: An Update Gary A. Giovino, PhD, MS University at Buffalo School of Public Health and Health Professions Overview! Conceptual models of surveillance/evaluation! Relevant
More informationStage Based Interventions for Tobacco Cessation
Precontemplation Stage Based Interventions for Tobacco Cessation Relapse Contemplation Preparation Action Maintenance Theoretical and practical considerations related to Movement through the Stages of
More informationADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL
ADENIYI MOFOLUWAKE MPH 510 - APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL 4 2013 Question 1: What makes the first study a case-control study? The first case study is a case-control study because
More informationAhmad Khosravi, Mohammad Ali Mansournia, Mahmood Mahmoodi, Ali Akbar Pouyan 1, Kourosh Holakouie Naieni
International Journal of Preventive Medicine Original Article Open Access Estimating the Transitional Probabilities of Smoking Stages with Cross sectional Data and 10 Year Projection for Smoking Behavior
More informationMassachusetts Department of Public Health, Tobacco Cessation and Prevention Program. Massachusetts spends $4.3 billion on
Massachusetts Tobacco Cessation and Prevention Program Winnable Battles Initiative June 6-8 Massachusetts Department of Public Health, Tobacco Cessation and Prevention Program Context Massachusetts spends
More informationTechnical Appendix I26,I27.1,I28,I43-45,I47.0- I47.1,I47.9,I48,I ,I51.0- I51.4,I52,I77-I84,I86-I97,I98.1-I98.8,I99
Technical Appendix Methods Multi-state life tables were used to determine remaining Health-adjusted life expectancy (HALE) 1,2 of Australian adults aged 35 to 80 years of age in the year 2000 divided amongst
More information10/27/15. Presenter Disclosures. Objec4ve. Winston Liao. 143 rd Annual APHA. Winston Liao. No relationships to disclose
Winston Liao 143 rd Annual APHA November 3, 2015 Presenter Disclosures Winston Liao No relationships to disclose Objec4ve Ø Describe the public health burden of COPD from a data perspective Present epidemiologic
More informationFigure 1 Modelling of diseases in PRIMEtime (after Barendregt et al. [7])
PRIMEtime PRIMEtime is a new model that combines elements of the PRIME model [1], which estimates the effect of population-level changes in diet, physical activity, and alcohol and tobacco consumption
More informationStudy population The study population comprised type 1 and 2 diabetic patients without renal complications.
Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines van Os N, Niessen L W, Bilo H J, Casparie A F, van Hout B A Record Status This is a critical abstract
More informationSmoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study
European Heart Journal (24) 25, 49 45 Clinical research Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study Abdullah
More informationNorthern Tobacco Use Monitoring Survey Northwest Territories Report. Health and Social Services
Northern Tobacco Use Monitoring Survey 2004 Northwest Territories Report Health and Social Services 1.0 Introduction The Canadian Tobacco Use Monitoring Survey (CTUMS) was initiated in 1999 to provide
More informationA REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE :
A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE : RESULTS FROM ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 2000 Delaware Health and Social Services Division
More informationGender Differences in Use of Smoking Cessation Services and Resources: A Real-World Study of Ontario Smokers
PROJECT NEWS July 2018 Gender Differences in Use of Smoking Cessation Services and Resources: A Real-World Study of Ontario Smokers Smoking cessation greatly reduces the health burden of tobacco use. 1,2
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationTable Of Content. Page 1/7
Table Of Content Closing the Gap - Reducing Premature Mortality. Baseline for Monitoring Health Evolution Following Enlargement... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Outputs...
More informationTobacco dependence: Implications for service provision
Tobacco dependence: Implications for service provision Andy McEwen, PhD University College London & National Centre for Smoking Cessation and Training (NCSCT) Tuesday 29th January 2013 Cardiff Conflict
More informationText 1: E-Cigarettes, the solution or another risk factor?
Text 1: E-Cigarettes, the solution or another risk factor? This excerpt is from Medpage Today 'HypeWatch: E-Cigs Best Cessation Tool Ever, Really?' Published: May 20, 2014 A retrospective analysis comparing
More informationStudy population The study population comprised a hypothetical cohort of poorly reversible COPD patients with a history of exacerbations.
Development of an economic model to assess the cost-effectiveness of treatment interventions for chronic obstructive pulmonary disease Spencer M, Briggs A H, Grossman R F, Rance L Record Status This is
More informationQuitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H
Quitline in smoking cessation: a cost-effectiveness analysis Tomson T, Helgason A R, Gilljam H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion
More informationSmoking Rates and Tobacco Cessation Coverage in Medicaid Expansion
Smoking Rates and Tobacco Cessation Coverage in Medicaid Expansion On December 8, 2016, State Medicaid Expansion Tobacco Cessation Coverage and Number of Adult Smokers Enrolled in Expansion Coverage United
More informationModeling the Population Health Effects of Camel Snus with Reduced Risk Information
Modeling the Population Health Effects of Camel Snus with Reduced Risk Information Geoffrey Curtin, Ph.D. - RAI Services Company Annette Bachand, Ph.D., Sandra Sulsky, Ph.D. - Ramboll Environ; Saul Shiffman,
More informationA randomized trial comparing two Internetbased smoking cessation programs
A randomized trial comparing two Internetbased smoking cessation programs Jean-François ETTER Faculty of Medicine, University of Geneva, Switzerland E-mail: Jean-Francois.Etter@unige.ch Acknowledgements
More informationCrossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countriesvhe_
Volume 13 Number 2 2010 VALUE IN HEALTH Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countriesvhe_612 230..241 Pepijn Vemer,
More informationProjections for smoking prevalence in New Zealand: Business-as-usual and with increased tobacco tax
1 Projections for smoking prevalence in New Zealand: Business-as-usual and with increased tobacco tax Nick Wilson (presenter), Frederieke S. van der Deen, Tak Ikeda, Linda Cobiac, Tony Blakely October
More informationPotential effect of salt reduction in processed foods on health 1 3
Potential effect of salt reduction in processed foods on health 1 3 Marieke AH Hendriksen, Rudolf T Hoogenveen, Jeljer Hoekstra, Johanna M Geleijnse, Hendriek C Boshuizen, and Joop MA van Raaij ABSTRACT
More informationName: CQ4 DP1 What actions are needed to address Australia s health priorities?
Name: CQ4 DP1 What actions are needed to address Australia s health priorities? health promotion based on the five action areas of the Ottawa Charter levels of responsibility for health promotion the benefits
More informationHow Might Medicinal Regulators Evolve in their Expectations for ENDS? David M Graham Chief Impact Officer - NJOY
How Might Medicinal Regulators Evolve in their Expectations for ENDS? David M Graham Chief Impact Officer - NJOY 4 Years Ago The Regulation of Nicotine-Containing Products Jeremy Mean 2015 The fact that
More informationSmoking cessation interventions and services
National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These
More informationIdentifying best practice in actions on tobacco smoking to reduce health inequalities
Identifying best practice in actions on tobacco smoking to reduce health inequalities An Matrix Knowledge Report to the Consumers, Health and Food Executive Agency, funded by the Health Programme of the
More informationQuantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines. Patrick Ryan 21 April 2010
Quantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines Patrick Ryan 21 April 2010 Challenges in understanding the effects of medicines Benefit
More informationCost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C
Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation Nielsen K, Fiore M C Record Status This is a critical abstract of an economic evaluation that meets the
More informationChanges in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS
Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS David M. Burns, Jacqueline M. Major, Thomas G. Shanks INTRODUCTION Smoking norms and behaviors have
More informationDP Program 2 National Comprehensive Cancer Control Program. Objective Reviewer s Tool March 2017
DP17-1701 Program 2 National Comprehensive Cancer Control Program Objective Reviewer s Tool March 2017 Approach (0-40 total points) Describes the cancer burden in the applicant s jurisdiction? (5) Clearly
More informationTobacco Use Screening and Counseling: Technical Report Prepared for the National Commission on Prevention Priorities
Tobacco Use Screening and Counseling: Technical Report Prepared for the National Commission on Prevention Priorities Version 06.1; last updated May 11, 2006 Prepared by Leif I. Solberg, MD* Michael V.
More informationBrief interventions delivered in GP surgeries to improve quit rates
Brief interventions delivered in GP surgeries to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England
More informationHAMILTON COUNTY DATA PROFILE ADULT CIGARETTE SMOKING. North Country Population Health Improvement Program
HAMILTON COUNTY DATA PROFILE ADULT CIGARETTE SMOKING North Country Population Health Improvement Program HAMILTON COUNTY DATA PROFILE: ADULT CIGARETTE SMOKING INTRODUCTION The Hamilton County Data Profile
More informationAnnex 1: MINDMAP research teams
Annex 1: MINDMAP research teams The Department of Public Health from the Erasmus MC in Rotterdam is a leading centre of public health research both within the Netherlands, and internationally and it is
More informationIs the AAA screening of any value in women?
Is the AAA screening of any value in women? A. Karkamanis Vascular Surgeon Dept. of Vascular Surgery Uppsala University SWEDEN Why screening women for AAA? consistently display a much lower AAA prevalence
More informationHPA tobacco control research programme. Tobacco Control Webinar June 2016
HPA tobacco control research programme Tobacco Control Webinar June 2016 Acknowledgements The work presented today represents significant input from: Hayley Guiney Joanna White Judy Li Holly Trowland Sicily
More informationSave Lives and Save Money
Tobacco Control Policies & Programs Save Lives and Save Money Matthew L. Myers President, Campaign for Tobacco Free Kids Alliance for Health Reform Luncheon Briefing July 13, 2012 1 We Know How to Reduce
More informationMeasuring cancer survival in populations: relative survival vs cancer-specific survival
Int. J. Epidemiol. Advance Access published February 8, 2010 Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2010; all rights reserved. International
More informationNicotine replacement therapy to improve quit rates
Nicotine replacement therapy to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England to undertake a
More informationSample Evaluation Plan. Indicator 4.1.1
Sample Evaluation Plan Indicator 4.1.1 Number of culturally and linguistically appropriate behavior modification-based tobacco cessation services that are available and well utilized in the community Objective:
More informationClinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R
Clinical impact and health economic consequences of post-transplant type 2 diabetes mellitus Chilcott J B, Whitby S M, Moore R Record Status This is a critical abstract of an economic evaluation that meets
More informationAssessing Access to Smoking Cessation Resources in Rural Populations
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Assessing Access to Smoking Cessation Resources in Rural Populations Tristan McKnight
More informationCEASE: A novel electronic patient directed knowledge translation tool to improve smoking cessation in cancer patients
CEASE: A novel electronic patient directed knowledge translation tool to improve smoking cessation in cancer patients Meredith Giuliani, Geoffrey Liu, Mihaela Dirlea, Victoria Milne, Peter Selby, David
More informationProgress toward quitting. The cessation environment in New York
Progress toward quitting The cessation environment in New York TCP Vision and Mission Vision: All New Yorkers live in a tobacco free society. Mission: Reduce morbidity and mortality and alleviate social
More informationColorado s Progress toward Year 2000 Objectives
Colorado s Progress toward Year Objectives An update from the Survey Research Unit No. 26 November 1998 Two major roles of Public Health are to reduce preventable death and disability and to enhance quality
More informationA REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE
A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE RESULTS FROM THE ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 00 Delaware Health and Social Services Division
More informationRADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS
Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics
More informationThe effectiveness of smoking cessation treatments used in the "real world"
Medizinische Fakultät The effectiveness of smoking cessation treatments used in the "real world" Daniel Kotz, PhD 11 March 2015 Heinrich-Heine-University Düsseldorf Maastricht University University College
More informationSetting The setting was a hospital and the community. The economic analysis was carried out in the USA.
Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs Halpern M T, Khan Z M, Young T L, Battista C Record Status This is a critical abstract
More informationTobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses. At-a-Glance:
Tobacco Reduction as a National & Regional Priority: Issuing a Challenge for Tobacco-Free Campuses RADM Clara H. Cobb Assistant Surgeon General U.S. Department of Health and Human Services Regional Health
More informationMy Background. State of Behavioral Health. State of Behavioral Health. Tailoring the Messages and the Medicines to Optimize Cessation Interventions
Tailoring the Messages and the Medicines to Optimize Cessation Interventions Stephen S. Michael, MS Director, ASHLine My Background Master s Degree in Rehabilitation Counseling 20+ years developing and
More informationA. Green, C. Sortsø, P.B. Jensen, M. Emneus
A. Green, C. Sortsø, P.B. Jensen, M. Emneus European Diabetes Epidemiology Group EDEG 2015, Chantilly, April 25-27, 2015 The Diabetes Impact Study 2013 uses all available register information on diabetes
More information